Hata Tomoko | Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
スポンサーリンク
概要
- 同名の論文著者
- Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University Gの論文著者
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G | 論文
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study